Refine by
Surgery Endoscopy Articles & Analysis
33 news found
On 23-24th September, 2021, the annual European Bariatric Endoscopic Surgery Trends (BEST) was successfully held in Montpellier, France. The BEST congress adopted a unique mode of online and offline access, bringing global experts and scholars together to discuss the cutting-edge progress in the field of bariatric surgery. Ezisurg Medical was honored to become the platinum partner of BEST, and ...
Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced a 24 Consecutive Patient Case Series detailing an endoscopic, stand-alone TLIF surgical technique used with the VariLift-LX System has been published in the Journal of Spine, Volume 7, Issue 2. The Case Series, authored by Kai-Uwe ...
BlueWind Medical, in preparation for commercialization of the RENOVA product line, announces the hiring of key positions within the organization. Vice President of Sales Mike Ruger, Vice President of Marketing Sandra Muhlfeld, and Vice President of Human Resources Lisa Mead. BlueWind Medical, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment ...
CDx Diagnostics, Inc. is pleased to announce that it has signed an agreement with laboratory benefits management provider Avalon Healthcare Solutions, Inc. of Tampa, Fla. The agreement means that CDx will be an in-network specialty anatomic pathology laboratory of Avalon client BlueCross BlueShield of South Carolina, and builds on Avalon’s positive medical policy for CDx’s proprietary ...
Lazurite’s new ArthroFree™ Wireless Surgical Camera System recently became the first such system to receive 510(k) market clearance from the Food and Drug Administration (FDA) for arthroscopy and general endoscopy. Surgeons using the ArthroFree System will be able to visualize the surgical field during minimally invasive surgery without the cumbersome ...
WATS3D, an AI powered diagnostic platform developed by CDx Diagnostics to empower physicians to reliably detect Barrett’s esophagus (BE) and esophageal dysplasia to help prevent esophageal cancer, was designated as medically necessary by Highmark, Inc. health plans in Delaware, Pennsylvania, and West Virginia in Q4 2021. CDx Diagnostics is pleased to share, that effective immediately, ...
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of Adhesion Formation in Patients Undergoing Bowel Resection Surgery Company to Host Conference Call on Wednesday, March 16, 2022, at 8:30 a.m. EST Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) ...
“We have been at the forefront of image-guided surgery with novel molecular markers and advanced imaging modalities for several years. ...
Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, was selected to present an ePoster entitled “Pooled-Analysis of Incidence and Severity of Post-Surgical Intraabdominal Adhesions following Bowel Resection Surgery and Treatment with Enteral Protease Inhibitor LB1148” at The Next ...
A newly published study as lead article in Gastrointestinal Endoscopy shows that Barrett’s esophagus (BE) and dysplasia progress to esophageal cancer at similar, or even higher, rates when diagnosed by WATS3D (wide-area transepithelial sampling with three-dimensional analysis) as they do when diagnosed by conventional forceps biopsies. This study titled “Progression of ...
Medical device and technology company Lazurite Holdings LLC today announced a new phase of collaboration with University Hospitals (UH) Ventures, the innovation and commercialization arm of University Hospitals Health System in Cleveland, which will include an investment from UH Ventures. The amount and details of the investment were not specified. This past August, Lazurite announced its ...
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL® following endoscopic sinus surgery had statistically significant lower healthcare resource utilization over a postoperative ...
Theramx announced on the 14th that it has signed an annual export contract with the Madrid Regional Health Agency, Spain, and has completed the delivery of the product. The product exported to Spain is EG-Q Bond, a bioadhesive for epidermal bonding that joins the affected area without using a separate suture for 20,000 endoscopic and laparoscopic surgeries. A Theramx official said, ...
Food and Drug Administration (FDA) for its ArthroFree™ wireless camera system for minimally invasive surgery, and that the submission has been accepted for review. The company also announced that early-stage healthcare investment platform AngelMD named it one of the best startup companies of 2021. ...
“With the recent completion of enrollment in the OASIS pivotal study, and the potential for FDA marketing clearance in 2023, we are preparing for commercialization and our next phase of corporate growth”, said Dan Lemaitre, Chairman and CEO of BlueWind Medical. “We believe that RENOVA’s minimally invasive and patient centric approach to the treatment of Overactive Bladder ...
Medical device and technology company Lazurite Holdings LLC has been recognized by MedTech Outlook magazine as a 2021 Top 10 Endoscopy Device Provider for its ArthroFree™ wireless camera system for minimally invasive surgery. MedTech Outlook describes itself as a platform that bridges the spectrum between medtech technology providers and healthcare ...
WATS3D, a diagnostic platform developed by CDx Diagnostics to empower physicians to detect Barrett’s esophagus (BE) and esophageal dysplasia, has been designated as medically necessary by Highmark Blue Cross Blue Shield plans in Delaware, Pennsylvania, and West Virginia. Clinically proven to significantly increase the detection rate of BE, pre-cancer, and cancerous cells in the esophagus ...
Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken Wiesbaden in Germany was the first hospital outside the United States to offer the Company’s PROPEL® Contour (mometasone furoate) sinus implant following functional endoscopic ...
EZ Glide, the most recent enhancement to Lumendi’s DiLumen Endoluminal Interventional Platform (EIP), has achieved significant quarter-over-quarter product sales since its market introduction in Q4 2020, and is on track to double the sales revenue from the prior year. Launched in December 2020, EZ Glide is helping to significantly increase the platform’s useability in GI ...
Introduction Pr Mohamed Badr-El-Dine (President of the IWGEES, President of the Egyptian Society of Skull Base Surgery) Pr Vincent Couloigner (Secretary-General SFORL, Paris, France) Mr Nicolas Prévost (CEO Collin SAS, Bagneux, France) RobOtol® assisted endoscopic surgery : feedback on the first patients Pr Yann Nguyen (Paris, France) ...